An overview of 3 phase II trials of navelbine (NVB), and fractionated doses of cisplstin (CDDP) in the management of advanced non-small cell lung cancer (NSCLC) von Pawlicki, M., Rodrigues, J., Firat, D., Altino, J., Krawczyk, K., Le Bras, Barista F., Burillon, J.P., Delgado, F.M.

Volltext

63 Navelbine (NVB), and fractionated doses of cisplatin (CDDP) — 20 mg/m2/5 days — in the management of advanced non-small cell lung cancer: An overview of 3 phase II trials von Rodrigues, J., Pawlicki, M., Firat, D., Altino, J., Krawczyk, K., Barista, Le Bras, F., Burillon, J.P., Delgado, F.M.

Volltext

63 Navelbine (NVB), and fractionated doses of cisplatin (CDDP) — 20 mg/m 2/5 days — in the management of advanced non-small cell lung cancer: An overview of 3 phase II trials von Rodrigues, J., Pawlicki, M., Firat, D., Altino, J., Krawczyk, K., Barista, Le Bras, F., Burillon, J.P., Delgado, F.M.

Volltext